Influenza Viruses

Principles and Practice of Pediatric Infectious Diseases, Fourth Edition

Volumn , Issue , 2012, Pages 1149-1159.e7

  Dawood, Fatimah S ^a   Subbarao, Kanta ^b   Fiore, Anthony E ^c  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872821706     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2702-9.00231-2     Document Type: Chapter

References (271)

1. Influenza vaccines. Weekly Epidemiological Record 2005;33:279–287.
2. Estimates of deaths associated with seasonal influenza – United States, 1976–2007. MMWR Morb Mortal Wkly Rep 59 1057-1062.
3. WW Thompson, DK Shay, E Weintraub, et al. (2004) Influenza-associated hospitalizations in the United States. JAMA 292 1333-1340.
4. FS Dawood, A Fiore, L Kamimoto, et al. (2010) Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. J Pediatr 157 808-814.
5. CG Grijalva, AS Craig, WD Dupont, et al. (2006) Estimating influenza hospitalizations among children. Emerg Infect Dis 12 103-109.
6. HS Izurieta, WW Thompson, P Kramarz, et al. (2000) Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342 232-239.
7. KM Neuzil, BG Mellen, PF Wright, et al. (2000) The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 342 225-231.
8. KA Poehling, KM Edwards, GA Weinberg, et al. (2006) The underrecognized burden of influenza in young children. N Engl J Med 355 31-40.
9. MA O'Brien, TM Uyeki, DK Shay, et al. (2004) Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 113 585-593.
10. WP Glezen, SB Greenberg, RL Atmar, et al. (2000) Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283 499-505.
11. MR Griffin, FJ Walker, MK Iwane, et al. (2004) Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network. Pediatr Infect Dis J 23 S188-S192.
12. WW Thompson, DK Shay, E Weintraub, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 179-186.
13. Estimates of deaths associated with seasonal influenza – United States, 1976–2007. MMWR Morb Mortal Wkly Rep 59 1057-1062.
14. E Bautista, T Chotpitayasunondh, Z Gao, et al. (2010) Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362 1708-1719.
15. Prevention and Control of Influenza with Vaccines (2010) Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59(RR-8), 1-62.
16. P Palese and M Shaw (2007) Orthomyxoviridae: the viruses and their replication. D Knipe, P Howley,(Eds) Fields Virology Philadelphia, PA, Lippincott: Williams and Wilkins 1647-1690.
17. KG Murti and RG Webster (1986) Distribution of hemagglutinin and neuraminidase on influenza virions as revealed by immunoelectron microscopy. Virology 149 36-43.
18. BA Askonas (1989) The Niels Jerne lecture. Influenza virus, a challenge to immunologists. Res Immunol 140 627-634.
19. D Hobson, RL Curry, AS Beare and A Ward-Gardner (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70 767-777.
20. BR Murphy, JA Kasel and RM Chanock (1972) Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med 286 1329-1332.
21. G Herrler, A Nagele, H Meier-Ewert, et al. (1981) Isolation and structural analysis of influenza C virion glycoproteins. Virology 113 439-451.
22. DC Wiley and JJ Skehel (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56 365-394.
23. Y Kawaoka and RG Webster (1988) Molecular mechanism of acquisition of virulence in influenza virus in nature. Microb Pathog 5 311-318.
24. G Neumann and Y Kawaoka (2006) Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis 12 881-886.
25. K Shinya, M Ebina, S Yamada, et al. (2006) Avian flu: influenza virus receptors in the human airway. Nature 440 435-436.
26. D van Riel, VJ Munster, E de Wit, et al. (2006) H5N1 Virus attachment to lower respiratory tract. Science 312 399.
27. PM Colman, JN Varghese and WG Laver (1983) Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303 41-44.
28. RG Webster, WJ Bean, OT Gorman, et al. (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56 152-179.
29. A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull World Health Organ 58 585-591.
30. NJ Cox and K Subbarao (1999) Influenza. Lancet 354 1277-1282.
31. C Scholtissek (1995) Molecular evolution of influenza viruses. Virus Genes 11 209-215.
32. FS Dawood, S Jain, L Finelli, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360 2605-2615.
33. RJ Garten, CT Davis, CA Russell, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325 197-201.
34. R Rabadan, AJ Levine and H Robins (2006) Comparison of avian and human influenza A viruses reveals a mutational bias on the viral genomes. J Virol 80 11887-11891.
35. AH Reid, TG Fanning, JV Hultin and JK Taubenberger (1999) Origin and evolution of the 1918 “Spanish” influenza virus hemagglutinin gene. Proc Natl Acad Sci U S A 96 1651-1656.
36. L Qi, JC Kash, VG Dugan, et al. (2009) Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J Virol 83 3754-3761.
37. CB Bridges, MJ Kuehnert and CB Hall (2003) Transmission of influenza: implications for control in health care settings. Clin Infect Dis 37 1094-1101.
38. R Tellier (2006) Review of aerosol transmission of influenza A virus. Emerg Infect Dis 12 1657-1662.
39. TP Weber and NI Stilianakis (2008) Inactivation of influenza A viruses in the environment and modes of transmission: a critical review. J Infect 57 361-373.
40. CB Hall (2007) The spread of influenza and other respiratory viruses: complexities and conjectures. Clin Infect Dis 45 353-359.
41. KC Klontz, NA Hynes, RA Gunn, et al. (1989) An outbreak of influenza A/Taiwan/1/86 (H1N1) infections at a naval base and its association with airplane travel. Am J Epidemiol 129 341-348.
42. MR Moser, TR Bender, HS Margolis, et al. (1979) An outbreak of influenza aboard a commercial airliner. Am J Epidemiol 110 1-6.
43. AL Frank, LH Taber, CR Wells, et al. (1981) Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 144 433-441.
44. FG Hayden (1997) Prevention and treatment of influenza in immunocompromised patients. Am J Med 102 55-60. discussion 75–6
45. JJ Walsh, LF Dietlein, FN Low, et al. (1961) Bronchotracheal response in human influenza. Type A, Asian strain, as studied by light and electron microscopic examination of bronchoscopic biopsies. Arch Intern Med 108 376-388.
46. FG Hayden, R Fritz, MC Lobo, et al. (1998) Local and systemic cytokine responses during experimental human influenza A virus infection: relation to symptom formation and host defense. J Clin Invest 101 643-649.
47. L Kaiser, RS Fritz, SE Straus, et al. (2001) Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 64 262-268.
48. VS Hinshaw, CW Olsen, N Dybdahl-Sissoko and D Evans (1994) Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol 68 3667-3673.
49. AJ McMichael, FM Gotch, G Noble and PA Beare (1983) Cytotoxic T-cell immunity to influenza. N Engl J Med 309 13-17.
50. E Rocha, NJ Cox, RA Black, et al. (1991) Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol 65 2340-2350.
51. J Yewdell and C Hackett (1989) Specificity and function of T lymphocytes induced by influenza A viruses. R Krug,(Eds) The Influenza Viruses New York: Plenum Press 361-429.
52. K Subbarao, BR Murphy and AS Fauci (2006) Development of effective vaccines against pandemic influenza. Immunity 24 5-9.
53. RU Zaman, AS Alamgir, M Rahman, et al. (2009) Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007–2008. PLoS One 4 e8452.
54. JM Simmerman, M Chittaganpitch, J Levy, et al. (2009) Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005–2008. PLoS One 4 e7776.
55. FE Moura, AC Perdigao and MM Siqueira (2009) Seasonality of influenza in the tropics: a distinct pattern in northeastern Brazil. Am J Trop Med Hyg 81 180-183.
56. MK Iwane, KM Edwards, PG Szilagyi, et al. (2004) Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 113 1758-1764.
57. KG Nicholson, T McNally, M Silverman, et al. (2006) Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children. Vaccine 24 102-108.
58. L Simonsen, K Fukuda, LB Schonberger and NJ Cox (2000) The impact of influenza epidemics on hospitalizations. J Infect Dis 181 831-837.
59. C Reed, FJ Angulo, DL Swerdlow, et al. (2009) Estimates of the prevalence of pandemic (H1N1) 2009, United States, April–July 2009. Emerg Infect Dis 15 2004-2007.
60. AL Frank, LH Taber, WP Glezen, et al. (1983) Influenza B virus infections in the community and the family: the epidemics of 1976–1977 and 1979–1980 in Houston, Texas. Am J Epidemiol 118 313-325.
61. AS Monto and F Kioumehr (1975) The Tecumseh Study of Respiratory Illness. IX: Occurrence of influenza in the community, 1966–1971. Am J Epidemiol 102 553-563.
62. WP Glezen (1980) Considerations of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis 2 408-420.
63. WP Glezen and RB Couch (1978) Interpandemic influenza in the Houston area, 1974–76. N Engl J Med 298 587-592.
64. KM Neuzil, C Hohlbein and Y Zhu (2002) Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Arch Pediatr Adolesc Med 156 986-991.
65. K Ampofo, PH Gesteland, J Bender, et al. (2006) Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 118 2409-2417.
66. SA Harper, K Fukuda, TM Uyeki, et al. (2005) Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 54 1-40.
67. KM Neuzil, PF Wright, EF Mitchel, Jr and MR Griffin (2000) The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 137 856-864.
68. R Keren, TE Zaoutis, CB Bridges, et al. (2005) Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 294 2188-2194.
69. N Bhat, JG Wright, KR Broder, et al. (2005) Influenza-associated deaths among children in the United States, 2003–2004. N Engl J Med 353 2559-2567.
70. L Finelli, A Fiore, R Dhara, et al. (2008) Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 122 805-811.
71. http://flu.gov/individualfamily/about/h1n1/estimates_2009_h1n1.html Updated CDC Estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009 – April 10, 2010. Accessed August 9, 2010, at
72. C Viboud, M Miller, D Olson, et al. (2010) Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the US and comparison with past influenza seasons. PLoS Curr Influenza RRN1153.
73. K Hancock, V Veguilla, X Lu, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361 1945-1952.
74. DJ Jamieson, MA Honein, SA Rasmussen, et al. (2009) H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 374 451-458.
75. JK Louie, M Acosta, DJ Jamieson and MA Honein (2010) Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 362 27-35.
76. AM Siston, SA Rasmussen, MA Honein, et al. (2010) Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 303 1517-1525.
77. S Jain, L Kamimoto, AM Bramley, et al. (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med 361 1935-1944.
78. OW Morgan, A Bramley, A Fowlkes, et al. (2010) Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 5 e9694.
79. R Meibalane, GV Sedmak, P Sasidharan, et al. (1977) Outbreak of influenza in a neonatal intensive care unit. J Pediatr 91 974-976.
80. YS Liou, SD Barbour, LM Bell and SA Plotkin (1987) Children hospitalized with influenza B infection. Pediatr Infect Dis J 6 541-543.
81. YH Wang, YC Huang, LY Chang, et al. (2003) Clinical characteristics of children with influenza A virus infection requiring hospitalization. J Microbiol Immunol Infect 36 111-116.
82. WP Glezen, A Paredes and LH Taber (1980) Influenza in children: relationship to other respiratory agents. JAMA 243 1345-1349.
83. S Meury, S Zeller and U Heininger (2004) Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents. Eur J Pediatr 163 359-363.
84. MJ Friedman and MW Attia (2004) Clinical predictors of influenza in children. Arch Pediatr Adolesc Med 158 391-394.
85. KM Edwards, MC Dundon and WA Altemeier (1983) Bacterial tracheitis as a complication of viral croup. Pediatr Infect Dis 2 390-391.
86. MA Downham, PS Gardner, J McQuillin and JA Ferris (1975) Role of respiratory viruses in childhood mortality. Br Med J 1 235-239.
87. JF Troendle, GJ Demmler, WP Glezen, et al. (1992) Fatal influenza B virus pneumonia in pediatric patients. Pediatr Infect Dis J 11 117-121.
88. PF Wright, J Thompson, KT McKee Jr, et al. (1981) Patterns of illness in the highly febrile young child: epidemiologic, clinical, and laboratory correlates. Pediatrics 67 694-700.
89. T Chonmaitree, K Revai, JJ Grady, et al. (2008) Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis 46 815-823.
90. H Monobe, T Ishibashi, Y Nomura, et al. (2003) Role of respiratory viruses in children with acute otitis media. Int J Pediatr Otorhinolaryngol 67 801-806.
91. H Yano, N Okitsu, T Hori, et al. (2009) Detection of respiratory viruses in nasopharyngeal secretions and middle ear fluid from children with acute otitis media. Acta Otolaryngol 129 19-24.
92. T Heikkinen (2000) Role of viruses in the pathogenesis of acute otitis media. Pediatr Infect Dis J 19 S17-S22. discussion S22–S23
93. K Ampofo, J Bender, X Sheng, et al. (2008) Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 122 229-237.
94. SE Coffin, TE Zaoutis, AB Rosenquist, et al. (2007) Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics 119 740-748.
95. JC Rojo, J Ruiz-Contreras, MB Fernandez, et al. (2006) Influenza-related hospitalizations in children younger than three years of age. Pediatr Infect Dis J 25 596-601.
96. JC Hageman, TM Uyeki, JS Francis, et al. (2006) Severe community-acquired pneumonia due to Staphylococcus aureus, 2003–04 influenza season. Emerg Infect Dis 12 894-899.
97. KL O'Brien, MI Walters, J Sellman, et al. (2000) Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 30 784-789.
98. KL MacDonald, MT Osterholm, CW Hedberg, et al. (1987) Toxic shock syndrome: a newly recognized complication of influenza and influenzalike illness. JAMA 257 1053-1058.
99. M Tashiro, P Ciborowski, HD Klenk, et al. (1987) Role of Staphylococcus protease in the development of influenza pneumonia. Nature 325 536-537.
100. SS Chiu, CY Tse, YL Lau and M Peiris (2001) Influenza A infection is an important cause of febrile seizures. Pediatrics 108 E63.
101. KL Kwong, SY Lam, TL Que and SN Wong (2006) Influenza A and febrile seizures in childhood. Pediatr Neurol 35 395-399.
102. SM Maricich, JL Neul, TE Lotze, et al. (2004) Neurologic complications associated with influenza A in children during the 2003–2004 influenza season in Houston, Texas. Pediatrics 114 e626-e633.
103. JG Newland, JR Romero, M Varman, et al. (2003) Encephalitis associated with influenza B virus infection in 2 children and a review of the literature. Clin Infect Dis 36 e87-e95.
104. T Morishima, T Togashi, S Yokota, et al. (2002) Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 35 512-517.
105. T Togashi, Y Matsuzono, M Narita and T Morishima (2004) Influenza-associated acute encephalopathy in Japanese children in 1994–2002. Virus Res 103 75-78.
106. Aspirin and Reye syndrome. Committee on Infectious Diseases. Pediatrics 69 810-812.
107. National Reye syndrome surveillance – United States, 1982 and 1983. MMWR Morb Mortal Wkly Rep 33 41-42.
108. P Agyeman, A Duppenthaler, U Heininger and C Aebi (2004) Influenza-associated myositis in children. Infection 32 199-203.
109. SP Conway, EJ Simmonds and JM Littlewood (1992) Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax 47 112-114.
110. CG Pribble, PG Black, JA Bosso and RB Turner (1990) Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J Pediatr 117 200-204.
111. 2009 pandemic influenza A (H1N1) virus infections – Chicago, Illinois, April–July 2009. MMWR Morb Mortal Wkly Rep 58 913-918.
112. A Bratincsak, HG El-Said, JS Bradley, et al. (2010) Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol 55 928-929.
113. LM Noriega, RJ Verdugo, R Araos, et al. (2010) Pandemic influenza A (H1N1) 2009 with neurological manifestations: a case series. Influenza Other Respir Viruses 4 117-120.
114. EA Belongia, SA Irving, SC Waring, et al. (2010) Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008–2009 (H1N1), and 2007–2008 (H3N2) infections. JAMA 304 1091-1098.
115. SR Wildin, T Chonmaitree and LE Swischuk (1988) Roentgenographic features of common pediatric viral respiratory tract infections. Am J Dis Child 142 43-46.
116. V Peltola, T Reunanen, T Ziegler, et al. (2005) Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis 41 1198-1200.
117. M Petric, L Comanor and CA Petti (2006) Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J Infect Dis 194(Suppl 2), S98-110.
118. F Carrat, E Vergu, NM Ferguson, et al. (2008) Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167 775-785.
119. GA Weinberg, DD Erdman, KM Edwards, et al. (2004) Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis 189 706-710.
120. S Bellau-Pujol, A Vabret, L Legrand, et al. (2005) Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. J Virol Methods 126 53-63.
121. G Boivin, S Cote, P Dery, et al. (2004) Multiplex real-time PCR assay for detection of influenza and human respiratory syncytial viruses. J Clin Microbiol 42 45-51.
122. J Fan, KJ Henrickson and LL Savatski (1998) Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex). Clin Infect Dis 26 1397-1402.
123. TM Uyeki (2003) Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 22 164-177.
124. CG Grijalva, KA Poehling, KM Edwards, et al. (2007) Accuracy and interpretation of rapid influenza tests in children. Pediatrics 119 e6-11.
125. RA Bright, DK Shay, B Shu, et al. (2006) Adamantane resistance among influenza A viruses isolated early during the 2005–2006 influenza season in the United States. JAMA 295 891-894.
126. NJ Dharan, LV Gubareva, JJ Meyer, et al. (2009) Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301 1034-1041.
127. A Moscona (2005) Neuraminidase inhibitors for influenza. N Engl J Med 353 1363-1373.
128. FG Hayden and AS Monto (1986) Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults. Antimicrob Agents Chemother 29 339-341.
129. LP Van Voris, RF Betts, FG Hayden, et al. (1981) Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA 245 1128-1131.
130. WL Wingfield, D Pollack and RR Grunert (1969) Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man. N Engl J Med 281 579-584.
131. CB Hall, R Dolin, CL Gala, et al. (1987) Children with influenza A infection: treatment with rimantadine. Pediatrics 80 275-282.
132. J Thompson, W Fleet, E Lawrence, et al. (1987) A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children. J Med Virol 21 249-255.
133. FG Hayden, RB Belshe, RD Clover, et al. (1989) Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 321 1696-1702.
134. Committee on Infectious Diseases, American Academy of Pediatrics (2007) Antiviral therapy and prophylaxis for influenza in children. Pediatrics 119 852-860.
135. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet 352 1877-1881.
136. FG Hayden, AD Osterhaus, JJ Treanor, et al. (1997) Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 337 874-880.
137. JA Hedrick, A Barzilai, U Behre, et al. (2000) Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatr Infect Dis J 19 410-417.
138. MJ Makela, K Pauksens, T Rostila, et al. (2000) Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J Infect 40 42-48.
139. AS Monto, DM Fleming, D Henry, et al. (1999) Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. J Infect Dis 180 254-261.
140. RJ Whitley, FG Hayden, KS Reisinger, et al. (2001) Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 20 127-133.
141. L Kaiser, C Wat, T Mills, et al. (2003) Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 163 1667-1672.
142. JJ Treanor, FG Hayden, PS Vrooman, et al. (2000) Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 283 1016-1024.
143. PA Piedra, KL Schulman and WA Blumentals (2009) Effects of oseltamivir on influenza-related complications in children with chronic medical conditions. Pediatrics 124 170-178.
144. EP Acosta, P Jester, P Gal, et al. (2010) Oseltamivir dosing for influenza infection in premature neonates. J Infect Dis 202 563-566.
145. DW Kimberlin, M Shalabi, MJ Abzug, et al. (2010) Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J 29 195-198.
146. LG Greer, JS Sheffield, VL Rogers, et al. (2010) Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet Gynecol 115 711-716.
147. AE Fiore, A Fry, D Shay, et al. (2011) Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 60 1-24.
148. SA Harper, JS Bradley, JA Englund, et al. (2009) Seasonal influenza in adults and children – diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 48 1003-1032.
149. JK Louie, M Acosta, K Winter, et al. (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 302 1896-1902.
150. N Lee, PK Chan, DS Hui, et al. (2009) Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 200 492-500.
151. A McGeer, KA Green, A Plevneshi, et al. (2007) Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 45 1568-1575.
152. Centers for Disease Control and Prevention (2011) Update: influenza activity – United States, October 2–November 26, 2011. MMWR 60 1646-1649.
153. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis – North Carolina, 2009. MMWR Morb Mortal Wkly Rep 58 969-972.
154. LV Gubareva, MN Matrosovich, MK Brenner, et al. (1998) Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis 178 1257-1262.
155. AI Klimov, E Rocha, FG Hayden, et al. (1995) Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 172 1352-1355.
156. TJ Mauch, S Bratton, T Myers, et al. (1994) Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics 94 225-229.
157. E Whimbey, LS Elting, RB Couch, et al. (1994) Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 13 437-440.
158. MC Mendoza Sanchez, J Ruiz-Contreras, JL Vivanco, et al. (2006) Respiratory virus infections in children with cancer or HIV infection. J Pediatr Hematol Oncol 28 154-159.
159. J Aschan, O Ringden, P Ljungman, et al. (1989) Influenza B in transplant patients. Scand J Infect Dis 21 349-350.
160. P Ljungman, J Andersson, J Aschan, et al. (1993) Influenza A in immunocompromised patients. Clin Infect Dis 17 244-247.
161. E Whimbey, JA Englund and RB Couch (1997) Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 102 10-18. discussion 25–6
162. M Tomblyn, T Chiller, H Einsele, et al. (2009) Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface. Bone Marrow Transplant 44 453-455.
163. World Health Organization Antiviral use and the risk of drug resistance. Pandemic (H1N1) 2009 briefing note. http://www.who.int/csr/disease/swineflu/notes/h1n1_antiviral_use_20090925/en/index.html Accessed August 30, 2010 at
164. S Carr, NA Ilyushina, J Franks, et al. (2011) Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer. Pediatr Infect Dis J 30 284-288.
165. L Danzinger-Isakov and D Kumar (2009) Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 9(Suppl 4), S258-S262.
166. JP Cohen and C Macauley (1989) Susceptibility to influenza A in HIV-positive patients. JAMA 261 245.
167. AD Fine, CB Bridges, AM De Guzman, et al. (2001) Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. Clin Infect Dis 32 1784-1791.
168. KD Evans and MW Kline (1995) Prolonged influenza A infection responsive to rimantadine therapy in a human immunodeficiency virus-infected child. Pediatr Infect Dis J 14 332-334.
169. A Weinberg, LY Song, R Walker, et al. (2010) Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children. J Acquir Immune Defic Syndr 55 189-196.
170. EG Chadwick, G Chang, MD Decker, et al. (1994) Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 13 206-211.
171. MJ Levin, LY Song, T Fenton, et al. (2008) Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine 26 4210-4217.
172. AE Fiore, DK Shay, P Haber, et al. (2007) Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56(RR-6), 1-54.
173. AA Creanga, TF Johnson, SB Graitcer, et al. (2010) Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 115 717-726.
174. KM Neuzil, GW Reed, EF Mitchel, et al. (1998) Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 148 1094-1102.
175. Infectious Diseases Society of America IDSA policy on mandatory immunization of health care workers against seasonal and pandemic influenza. http://www.idsociety.org/hcwimmunization.htm Accessed August 31, 2010 at
176. American Academy of Pediatrics (2010) Policy statement – recommendations for mandatory influenza immunization of all healthcare personnel. Pediatrics 126 809-815.
177. Academy of Pediatrics (2011) Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2011–2012. Pediatrics 128 813-825.
178. JP Fox, MK Cooney, CE Hall and HM Foy (1982) Influenzavirus infections in Seattle families, 1975–1979. II: Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 116 228-242.
179. JP Fox, CE Hall, MK Cooney and HM Foy (1982) Influenzavirus infections in Seattle families, 1975–1979. I: Study design, methods and the occurrence of infections by time and age. Am J Epidemiol 116 212-227.
180. AS Monto, JS Koopman and IM Longini Jr (1985) Tecumseh study of illness. XIII: Influenza infection and disease, 1976–1981. Am J Epidemiol 121 811-822.
181. S Esposito, P Marchisio, R Cavagna, et al. (2003) Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine 21 3162-3168.
182. ES Hurwitz, M Haber, A Chang, et al. (2000) Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 284 1677-1682.
183. M Loeb, ML Russell, L Moss, et al. (2010) Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 303 943-950.
184. AS Monto, FM Davenport, JA Napier and T Francis Jr (1969) Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic. Bull World Health Organ 41 537-542.
185. D Weycker, J Edelsberg, ME Halloran, et al. (2005) Population-wide benefits of routine vaccination of children against influenza. Vaccine 23 1284-1293.
186. I Stephenson, F Hayden, A Osterhaus, et al. (2010) Report of the fourth meeting on “Influenza vaccines that induce broad spectrum and long-lasting immune responses”, World Health Organization and Wellcome Trust, London, United Kingdom, 9–10 November 2009. Vaccine 28 3875-3882.
187. PF Wright, J Thompson, WK Vaughn, et al. (1977) Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. J Infect Dis 136(Suppl), S731-S741.
188. DI Bernstein, JM Zahradnik, CJ DeAngelis and JD Cherry (1982) Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines. Am J Dis Child 136 513-517.
189. KM Neuzil, LA Jackson, J Nelson, et al. (2006) Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5–8-year-old children. J Infect Dis 194 1032-1039.
190. KM Neuzil, WD Dupont, PF Wright and KM Edwards (2001) Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 20 733-740.
191. KW Eisenberg, PG Szilagyi, G Fairbrother, et al. (2008) Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003–2004 and 2004–2005 influenza seasons. Pediatrics 122 911-919.
192. CM Shuler, M Iwamoto, CB Bridges, et al. (2007) Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003–2004. Pediatrics 119 e587-95.
193. PG Szilagyi, G Fairbrother, MR Griffin, et al. (2008) Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Arch Pediatr Adolesc Med 162 943-951.
194. DA Clements, L Langdon, C Bland and E Walter (1995) Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med 149 1113-1117.
195. T Heikkinen, O Ruuskanen, M Waris, et al. (1991) Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 145 445-448.
196. A Hoberman, DP Greenberg, JL Paradise, et al. (2003) Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 290 1608-1616.
197. CL Park, AL Frank, M Sullivan, et al. (1996) Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 98 196-200.
198. P Kramarz, F Destefano, PM Gargiullo, et al. (2001) Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 138 306-310.
199. BA Ong, J Forester and A Fallot (2009) Does influenza vaccination improve pediatric asthma outcomes? J Asthma 46 477-480.
200. KL Huang, FL Ruben, CR Rinaldo Jr, et al. (1987) Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA 257 2047-2050.
201. SI Staprans, BL Hamilton, SE Follansbee, et al. (1995) Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 182 1727-1737.
202. JA Englund, IN Mbawuike, H Hammill, et al. (1993) Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 168 647-656.
203. MC Steinhoff, SB Omer, E Roy, et al. (2010) Influenza immunization in pregnancy: antibody responses in mothers and infants. N Engl J Med 362 1644-1646.
204. K Zaman, E Roy, S Arifeen, et al. (2008) Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 359 1555-1564.
205. AA Eick, TM Uyeki, A Klimov, et al. (2011) Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 165 104-111.
206. Centers for Disease Control and Prevention (2011) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 60 1128-1132.
207. V Vankerckhoven and P Van Damme (2010) Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines. Expert Opin Drug Deliv 7 1109-1125.
208. T Vesikari, DM Fleming, JF Aristegui, et al. (2006) Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 118 2298-2312.
209. RB Belshe, KM Edwards, T Vesikari, et al. (2007) Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 356 685-696.
210. R Bergen, S Black, H Shinefield, et al. (2004) Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 23 138-144.
211. CS Ambrose, T Yi and J Falloon (2011) An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2–17 years. Influenza Other Respi Viruses 5 389-397.
212. SL Block, R Yogev, FG Hayden, et al. (2008) Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age. Vaccine 26 4940-4946.
213. T Vesikari, A Karvonen, T Korhonen, et al. (2006) A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine. Pediatr Infect Dis J 25 590-595.
214. TA Cha, K Kao, J Zhao, et al. (2000) Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J Clin Microbiol 38 839-845.
215. JR La Montagne, GR Noble, GV Quinnan, et al. (1983) Summary of clinical trials of inactivated influenza vaccine – 1978. Rev Infect Dis 5 723-736.
216. RB Belshe, WC Gruber, PM Mendelman, et al. (2000) Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 136 168-175.
217. RB Belshe, PM Mendelman, J Treanor, et al. (1998) The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 338 1405-1412.
218. JS Tam, MR Capeding, LC Lum, et al. (2007) Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J 26 619-628.
219. MR Griffin, AS Monto, EA Belongia, et al. (2011) Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 US communities. PLoS One 6 e23085.
220. S Ashkenazi, A Vertruyen, J Aristegui, et al. (2006) Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 25 870-879.
221. DM Fleming, P Crovari, U Wahn, et al. (2006) Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 25 860-869.
222. XS He, TH Holmes, C Zhang, et al. (2006) Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 80 11756-11766.
223. S Sasaki, MC Jaimes, TH Holmes, et al. (2007) Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 81 215-228.
224. ME Halloran, PA Piedra, IM Longini Jr, et al. (2007) Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003–2004. Vaccine 25 4038-4045.
225. DF Hoft, E Babusis, S Worku, et al. (2011) Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 204 845-853.
226. SE Ohmit, JC Victor, JR Rotthoff, et al. (2006) Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 355 2513-2522.
227. SE Ohmit, JC Victor, ER Teich, et al. (2008) Prevention of symptomatic seasonal influenza in 2005–2006 by inactivated and live attenuated vaccines. J Infect Dis 198 312-317.
228. AS Monto, SE Ohmit, JG Petrie, et al. (2009) Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 361 1260-1267.
229. Z Wang, S Tobler, J Roayaei and A Eick (2009) Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. JAMA 301 945-953.
230. FG Hayden, R Belshe, C Villanueva, et al. (2004) Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis 189 440-449.
231. R Welliver, AS Monto, O Carewicz, et al. (2001) Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 285 748-754.
232. FG Hayden, LV Gubareva, AS Monto, et al. (2000) Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med 343 1282-1289.
233. AS Monto, AB Moult and SJ Sharp (2000) Effect of zanamivir on duration and resolution of influenza symptoms. Clin Ther 22 1294-1305.
234. N Khazeni, DM Bravata, JE Holty, et al. (2009) Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza. Ann Intern Med 151 464-473.
235. Centers for Disease Control and Prevention Novel influenza A virus infections. http://www.cdc.gov/ncphi/disss/nndss/casedef/novel_influenzaA.htm CSTE Position Statement Number: 09-ID-43. Accessed September 28, 2010 at
236. JA Belser, X Lu, TR Maines, et al. (2007) Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J Virol 81 11139-11147.
237. K Van Reeth (2007) Avian and swine influenza viruses: our current understanding of the zoonotic risk. Vet Res 38 243-260.
238. K Subbarao, A Klimov, J Katz, et al. (1998) Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279 393-396.
239. KY Yuen, PK Chan, M Peiris, et al. (1998) Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351 467-471.
240. Avian influenza A(H5N1). Wkly Epidemiol Rec 79 65-70.
241. TH Tran, TL Nguyen, TD Nguyen, et al. (2004) Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 350 1179-1188.
242. JH Beigel, J Farrar, AM Han, et al. (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353 1374-1385.
243. K Ungchusak, P Auewarakul, SF Dowell, et al. (2005) Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 352 333-340.
244. H Wang, Z Feng, Y Shu, et al. (2008) Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 371 1427-1434.
245. T Chotpitayasunondh, K Ungchusak, W Hanshaoworakul, et al. (2005) Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 11 201-209.
246. A Apisarnthanarak, R Kitphati, K Thongphubeth, et al. (2004) Atypical avian influenza (H5N1). Emerg Infect Dis 10 1321-1324.
247. MD de Jong, VC Bach, TQ Phan, et al. (2005) Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 352 686-691.
248. A Kandeel, S Manoncourt, E Abd el Kareem, et al. (2010) Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006–2009. Emerg Infect Dis 16 1101-1107.
249. TM Uyeki (2009) Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 49 279-290.
250. K Chokephaibulkit, M Uiprasertkul, P Puthavathana, et al. (2005) A child with avian influenza A (H5N1) infection. Pediatr Infect Dis J 24 162-166.
251. IN Kandun, E Tresnaningsih, WH Purba, et al. (2008) Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet 372 744-749.
252. H Yu, Z Gao, Z Feng, et al. (2008) Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One 3 e2985.
253. New laboratory assay for diagnostic testing of avian influenza A/H5 (Asian Lineage). MMWR Morb Mortal Wkly Rep 55 127.
254. W Adisasmito, PK Chan, N Lee, et al. (2010) Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. J Infect Dis 202 1154-1160.
255. CL Cheung, JM Rayner, GJ Smith, et al. (2006) Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis 193 1626-1629.
256. MD de Jong, TT Tran, HK Truong, et al. (2005) Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353 2667-2672.
257. Centers for Disease Control and Prevention Updated interim guidance for laboratory testing of persons with suspected infection with highly pathogenic avian influenza A (H5N1) virus in the United States, 2009. http://www.cdc.gov/flu/avian/professional/guidance-labtesting.htm Accessed September 28, 2010 at
258. Prevention. CfDCa Interim guidance for follow-up of contacts of persons with suspected infection with highly pathogenic avian influenza A (H5N1) virus in the United States. http://www.cdc.gov/flu/avian/professional/guidance-followup.htm Accessed September 28, 2010 at
259. KP Myers, CW Olsen and GC Gray (2007) Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 44 1084-1088.
260. V Shinde, CB Bridges, TM Uyeki, et al. (2009) Triple-reassortant swine influenza A (H1) in humans in the United States, 2005–2009. N Engl J Med 360 2616-2625.
261. GC Gray, T McCarthy, AW Capuano, et al. (2007) Swine workers and swine influenza virus infections. Emerg Infect Dis 13 1871-1878.
262. KP Myers, CW Olsen, SF Setterquist, et al. (2006) Are swine workers in the United States at increased risk of infection with zoonotic influenza virus? Clin Infect Dis 42 14-20.
263. Centers for Disease Control and Prevention (2011) Limited human-to-human transmission of novel influenza A (H3N2) virus – Iowa, November 2011. MMWR Morb Mortal Wkly Rep 60 1615-1617.
264. Centers for Disease Control and Prevention (2011) Swine-origin influenza A (H3N2) virus infection in two children – Indiana and Pennsylvania, July–August 2011. MMWR Morb Mortal Wkly Rep 60 1213-1215.
265. Pandemic influenza preparedness and response: a WHO guidance document. http://www.who.int/csr/disease/influenza/PIPGuidance09.pdf Accessed August 8, 2010, at
266. NJ Cox and K Subbarao (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51 407-421.
267. RA Karron, K Talaat, C Luke, et al. (2009) Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine 27 4953-4960.
268. TM Nolan, PC Richmond, MV Skeljo, et al. (2008) Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults. Vaccine 26 4160-4167.
269. I Leroux-Roels, A Borkowski, T Vanwolleghem, et al. (2007) Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 370 580-589.
270. I Stephenson, KG Nicholson, K Hoschler, et al. (2008) Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. N Engl J Med 359 1631-1633.
271. A Patel and SE Gorman (2009) Stockpiling antiviral drugs for the next influenza pandemic. Clin Pharmacol Ther 86 241-243.